Philip Lowry

839 total citations
28 papers, 651 citations indexed

About

Philip Lowry is a scholar working on Hematology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Philip Lowry has authored 28 papers receiving a total of 651 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Hematology, 9 papers in Molecular Biology and 8 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Philip Lowry's work include Hematopoietic Stem Cell Transplantation (7 papers), Neonatal Respiratory Health Research (5 papers) and Virus-based gene therapy research (3 papers). Philip Lowry is often cited by papers focused on Hematopoietic Stem Cell Transplantation (7 papers), Neonatal Respiratory Health Research (5 papers) and Virus-based gene therapy research (3 papers). Philip Lowry collaborates with scholars based in United States, United Kingdom and Italy. Philip Lowry's co-authors include F. Marc Stewart, Pamela S. Becker, Stephen O. Heard, Richard S. Swanson, Germán Pihán, Simon Brockbank, Sinéad Weldon, Matthew S. Twigg, Clifford C. Taggart and Hayley S. Ramshaw and has published in prestigious journals such as Journal of Clinical Oncology, Blood and JNCI Journal of the National Cancer Institute.

In The Last Decade

Philip Lowry

28 papers receiving 633 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Philip Lowry United States 11 238 200 152 132 114 28 651
Tetsuro Okamoto Japan 17 145 0.6× 379 1.9× 144 0.9× 241 1.8× 92 0.8× 42 892
Balan Louis Gaspar India 10 165 0.7× 140 0.7× 150 1.0× 72 0.5× 79 0.7× 32 602
P. C. Vincent Australia 15 228 1.0× 135 0.7× 167 1.1× 116 0.9× 139 1.2× 59 817
Ana Cordeiro Gomes Portugal 12 337 1.4× 187 0.9× 163 1.1× 278 2.1× 180 1.6× 19 851
Taiki Suzuki Japan 16 216 0.9× 286 1.4× 113 0.7× 46 0.3× 87 0.8× 64 966
S Okamura Japan 17 167 0.7× 144 0.7× 180 1.2× 289 2.2× 81 0.7× 45 683
Issaka Yougbaré Canada 13 402 1.7× 236 1.2× 54 0.4× 177 1.3× 52 0.5× 23 847
Georges Andreu France 15 233 1.0× 243 1.2× 46 0.3× 139 1.1× 118 1.0× 22 914
Sonia Cellot Canada 14 276 1.2× 410 2.0× 184 1.2× 125 0.9× 60 0.5× 44 787
Dennis W. Ross United States 15 107 0.4× 191 1.0× 114 0.8× 53 0.4× 84 0.7× 43 604

Countries citing papers authored by Philip Lowry

Since Specialization
Citations

This map shows the geographic impact of Philip Lowry's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philip Lowry with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philip Lowry more than expected).

Fields of papers citing papers by Philip Lowry

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Philip Lowry. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philip Lowry. The network helps show where Philip Lowry may publish in the future.

Co-authorship network of co-authors of Philip Lowry

This figure shows the co-authorship network connecting the top 25 collaborators of Philip Lowry. A scholar is included among the top collaborators of Philip Lowry based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Philip Lowry. Philip Lowry is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dragnev, Konstantin H., Taofeek K. Owonikoko, Tibor Csőszi, et al.. (2018). Trilaciclib (T) decreases multi-lineage myelosuppression in extensive-stage small cell lung cancer (ES-SCLC) patients receiving first-line chemotherapy. Annals of Oncology. 29. viii597–viii597. 1 indexed citations
2.
Pant, Shubham, Alexander I. Spira, Byoung Chul Cho, et al.. (2018). Evaluation of the spectrum selective RTK inhibitor sitravatinib in clear cell renal cell carcinoma (ccRCC) refractory to anti-angiogenic therapy (AAT).. Journal of Clinical Oncology. 36(15_suppl). 4568–4568. 3 indexed citations
3.
Twigg, Matthew S., Simon Brockbank, Philip Lowry, et al.. (2015). Cleaved SLPI as a marker for exacerbation in cystic fibrosis. PA3876–PA3876. 1 indexed citations
4.
Singla, Anand, Dinesh Jagasia, Mukesh Garg, Philip Lowry, & Dwight Stapleton. (2012). Acute ST-segment elevation myocardial infarction: A rare initial presentation of previously undiagnosed essential thrombocythemia. Platelets. 23(6). 463–466. 6 indexed citations
5.
O’Mahony, John, Mary Moloney, R.I. McConnell, et al.. (2011). Simultaneous detection of four nitrofuran metabolites in honey using a multiplexing biochip screening assay. Biosensors and Bioelectronics. 26(10). 4076–4081. 37 indexed citations
6.
Gyurkocza, Boglarka, Janet Plescia, Christopher M. Raskett, et al.. (2006). Antileukemic Activity of Shepherdin and Molecular Diversity of Hsp90 Inhibitors. JNCI Journal of the National Cancer Institute. 98(15). 1068–1077. 66 indexed citations
7.
Becker, Pamela S., Adrianne N. Hanks, William Walsh, et al.. (2005). In Vivo Chemotherapy Protection and Efficacy of Multidrug Resistance (MDR-1) Gene Transfer in a Patient with Refractory Non-Hodgkin’s Lymphoma (NHL).. Blood. 106(11). 3054–3054. 1 indexed citations
8.
Gyurkocza, Boglarka, Janet Plescia, Dale L. Greiner, et al.. (2005). Antileukemic Activity of Shepherdin, a Novel Targeted Inhibitor of the Survivin-Hsp90 Complex.. Blood. 106(11). 242–242. 2 indexed citations
9.
Ballen, Karen K., Pamela S. Becker, Robert Emmons, et al.. (1999). Safety and Cost of Hyperhydration for the Prevention of Hemorrhagic Cystitis in Bone Marrow Transplant Recipients. Oncology. 57(4). 287–292. 20 indexed citations
10.
Lowry, Philip, et al.. (1998). Venous cavernous hemangioma of the testis. Urology. 52(4). 709–710. 9 indexed citations
11.
Becker, Pamela S., Richard S. Swanson, Germán Pihán, et al.. (1997). Spontaneous splenic rupture following administration of granulocyte colony-stimulating factor (G-CSF): occurrence in an allogeneic donor of peripheral blood stem cells.. PubMed. 3(1). 45–9. 141 indexed citations
12.
Lowry, Philip. (1995). Hematopoietic stem cell cytokine response. Journal of Cellular Biochemistry. 58(4). 410–415. 10 indexed citations
13.
Quesenberry, PJ, Hayley S. Ramshaw, S. Peters, et al.. (1994). Engraftment of normal murine marrow into nonmyeloablated host mice.. PubMed. 20(2-3). 348–50. 37 indexed citations
14.
Quesenberry, Peter J., RB Crittenden, Philip Lowry, et al.. (1994). In vitro and in vivo studies of stromal niches.. PubMed. 20(1). 97–104; discussion 104. 24 indexed citations
15.
Quesenberry, P. J., Ellen L. W. Kittler, Philip Lowry, & RB Crittenden. (1993). Stromal regulation of hemopoiesis and the role of subliminal growth factor production.. PubMed. 7 Suppl 2. S3–4. 6 indexed citations
16.
17.
Quesenberry, Peter J. & Philip Lowry. (1992). The colony-stimulating factors. An overview.. PubMed. 70(4 Suppl). 909–12. 3 indexed citations
18.
Quesenberry, P. J., Helen E. McGrath, Philip Lowry, et al.. (1991). Long‐term marrow cultures: human and murine systems. Journal of Cellular Biochemistry. 45(3). 273–278. 10 indexed citations
19.
May, Michael, Paul D. Mintz, Philip Lowry, Robert B. Geller, & Randall T. Curnow. (1983). Plasmapheresis in Thyroxine Overdose: A Case Report. Journal of Toxicology Clinical Toxicology. 20(5). 517–520. 24 indexed citations
20.
Lowry, Philip & Donal B. Murphy. (1981). Serological cross-reactivity between products of different Ia loci. Immunogenetics. 14(3-4). 189–201. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tetsuro Okamoto Breakdown of academic impact, for papers by Balan Louis Gaspar Breakdown of academic impact, for papers by P. C. Vincent Breakdown of academic impact, for papers by Ana Cordeiro Gomes Breakdown of academic impact, for papers by Taiki Suzuki Breakdown of academic impact, for papers by S Okamura Breakdown of academic impact, for papers by Issaka Yougbaré Breakdown of academic impact, for papers by Georges Andreu Breakdown of academic impact, for papers by Sonia Cellot Breakdown of academic impact, for papers by Dennis W. Ross
Rankless by CCL
2026